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We have developed an integrated continuous processing framework for end-to-end production of complex 
fragile proteins based on perfusion cultivation and automated multi-step purification [1,2]. Upstream, the 
integrated system consists of a stirred tank bioreactor with an ATF cell retention system. The clarified harvest 
directly enters an off-the-shelf ÄKTA chromatography system converted into a continuous purification unit. Two 
alternating capture columns precede a multi-step purification train with full flexibility and control of individual 
columns. 
 
The integrated set-up enables compact automated bench-top factories converting cell culture media to purified 
protein in an efficient manner without intermediate storage. It provides monitoring of the production progress 
allowing for “just-enough” production and better use of resources. Importantly, the integrated approach also 
enables continuous monitoring of product quality attributes. This aspect is obviously relevant in a manufacturing 
setting but perhaps even more so during process development to aid deciphering the relation between cell 
culture performance and product quality. 
 
Case studies from production of fragile proteins for pre-clinical supply will be presented. As an example of 
process intensification, the combination of the integrated continuous framework with a novel perfusion platform 
enabled laboratory-scale equipment to produce amounts that previously would have required pilot-scale 
resources. Examples with disturbances and/or deliberate changes and/or in the cell culture process during 





[1] Tiainen et al., End-to-end continuous production of complex recombinant proteins – integration of perfusion 
cultivation and automated multi-step purification [Abstract presented at Integrated Continuous Biomanufacturing 
I, Barcelona, Oct 2013] 
 
[2] Åkesson et al., Integrated continuous production - a bench-top factory framework for rapid preclinical supply 
of fragile proteins [Abstract presented at Cell Culture Engineering XIV, Quebec City, May 2014] 
 
